Benefits of shingles shot outweigh seniors’ risk of Guillain-Barré syndrome, federal investigators...
By
Alicia Lasek
Nov 11, 2021
Clinicians should be aware of these risks, but weigh them against the benefits of decreasing the likelihood of shingles and its complications, according to investigators from the CDC, FDA and CMS.
Clinical briefs for Thursday, Nov. 11
By
Alicia Lasek
Nov 11, 2021
The next hospital crisis may be dementia behavioral emergencies, psychiatrist says … Neurologists prescribing Alzheimer’s drug Aduhelm talk about practices and payments … Patients with diabetes may...
SNF-linked wound clinics saw fewer patients during pandemic but unchanged outcomes
By
Alicia Lasek
Nov 10, 2021
Investigators expected that wound outcomes would be adversely affected by pandemic disruptions. But data from hundreds of wound care clinics in the United States show otherwise.
Pfizer-BioNTech vaccine highly effective in octo- and nonagenarians, German study finds
By
Alicia Lasek
Nov 10, 2021
The data, from 700,000 older residents of Bavaria, resolves questions about the vaccine’s protectiveness that weren’t answered by the drugmaker’s clinical trials, investigators say.
Listening to favorite music may improve cognitive function of Alzheimer’s patients
By
Alicia Lasek
Nov 10, 2021
Music that holds a special meaning stimulates the brains of Alzheimer’s patients in key areas, a new study finds. The results support personalized, music-based interventions for people with dementia,...
Clinical briefs for Wednesday, Nov. 10
By
Alicia Lasek
Nov 10, 2021
Legal challenges aside, senior living operators advised to prepare for COVID-19 vaccine mandate … Patient treated with Alzheimer’s drug aducanumab has six brain abnormality episodes … Feds invest...
One shot of REGEN-COV prevents COVID infection for 8 months, clinical trial finds
By
Alicia Lasek
Nov 09, 2021
A single dose delivered by subcutaneous injection cut the 8-month risk of contracting COVID-19 by 82% — nearly the same rate of protection found at one month, the company announced Monday.
COVID pill could prevent 9 in 10 hospitalizations, Pfizer says
By
Alicia Lasek
Nov 09, 2021
The antiviral Paxlovid reduced the rate of hospitalization and death from COVID-19 by nearly 90% in a clinical trial. A similar oral antiviral made by Merck currently is under review by the FDA.
Free LTC infection prevention tool from Yale aims to help nursing home staff save time
By
Alicia Lasek
Nov 09, 2021
A one-stop set of infection prevention resources is meant to make work a bit easier for direct care providers, administrators, managers and support staff, say the Yale School of Nursing and the New York...
Clinical briefs for Tuesday, Nov. 9
By
Alicia Lasek
Nov 09, 2021
CMS to nursing homes: Start reviewing, planning and tracking staff COVID vaccinations now … Study: 9 out of 10 patients left skilled nursing for home during pandemic … New COVID-19 antiviral pills...